Literature DB >> 29607170

Prognostic factors for surgically resected non-small cell lung cancer with cavity formation.

Shunsuke Shigefuku1, Yujin Kudo1, Daisuke Yunaiyama2, Jun Matsubayashi3, Jinho Park2, Toshitaka Nagao3, Yoshihisa Shimada1, Hisashi Saji4, Masaru Hagiwara1, Tetsuya Okano1, Masatoshi Kakihana1, Naohiro Kajiwara1, Tatsuo Ohira1, Norihiko Ikeda1.   

Abstract

BACKGROUND: Small pulmonary nodules have been detected frequently by computed tomography (CT). Lung cancers with cavity formation are also easily detected. There are a few reports focused on the cavity wall, although cancer cells exist along the cavity wall, not inside. We evaluated the impact of cavity wall thickness on prognosis and assessed the clinicopathological features in non-small cell lung cancer (NSCLC) with cavity formation.
METHODS: Between 2005 and 2011, 1,313 patients underwent complete resection for NSCLC. Of these cases, we reviewed 65 patients (5.0%) diagnosed with NSCLC with cavity formation by chest CT. We classified the patients into three groups based on the maximum cavity wall thickness, namely, ≤4 mm (Group 1, 8 patients), >4 and ≤15 mm (Group 2, 33 patients), and >15 mm (Group 3, 24 patients).
RESULTS: The number of patients with pathological whole tumor size >3 cm was 2 (25%) in Group 1, 17 (52%) in Group 2, and 23 (96%) in Group 3 (P<0.001). Cases with lymph node metastasis were 0 (0%) in Group 1, 5 (15%) in Group 2, and 10 (42%) in Group 3 (P=0.016). The 5-year overall survival (OS) rates were 100% in Group 1, 84.0% in Group 2, and 52.0% in Group 3, with significant differences between Group 1 and Group 3 (P=0.044) and between Group 2 and Group 3 (P=0.034). In univariate analysis, neither whole tumor size nor lymph node metastasis was a prognostic factor for OS (P=0.51, P=0.27). Only cavity wall thickness was a significant prognostic factor by multivariate analysis (P=0.009).
CONCLUSIONS: Maximum cavity wall thickness was an important prognostic factor in NSCLCs with cavity formation, comparable with other established prognostic factors.

Entities:  

Keywords:  Cavity wall thickness; cavity; non-small cell lung cancer (NSCLC); prognostic factor; whole tumor size

Year:  2018        PMID: 29607170      PMCID: PMC5864647          DOI: 10.21037/jtd.2018.01.61

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN: 2072-1439            Impact factor:   2.895


  28 in total

1.  Conventional clinicopathologic prognostic factors in surgically resected nonsmall cell lung carcinoma. A comparison of prognostic factors for each pathologic TNM stage based on multivariate analyses.

Authors:  K Suzuki; K Nagai; J Yoshida; M Nishimura; K Takahashi; T Yokose; Y Nishiwaki
Journal:  Cancer       Date:  1999-11-15       Impact factor: 6.860

2.  Introduction to The 2015 World Health Organization Classification of Tumors of the Lung, Pleura, Thymus, and Heart.

Authors:  William D Travis; Elisabeth Brambilla; Allen P Burke; Alexander Marx; Andrew G Nicholson
Journal:  J Thorac Oncol       Date:  2015-09       Impact factor: 15.609

3.  Fleischner Society: glossary of terms for thoracic imaging.

Authors:  David M Hansell; Alexander A Bankier; Heber MacMahon; Theresa C McLoud; Nestor L Müller; Jacques Remy
Journal:  Radiology       Date:  2008-01-14       Impact factor: 11.105

4.  The prognostic impact of tumor volume on stage I non-small cell lung cancer.

Authors:  Xiao-Dong Su; Hao-Jun Xie; Qian-Wen Liu; Yun-Xian Mo; Hao Long; Tie-Hua Rong
Journal:  Lung Cancer       Date:  2016-12-21       Impact factor: 5.705

5.  Tumor cavitation in stage I non-small cell lung cancer: epidermal growth factor receptor expression and prediction of poor outcome.

Authors:  Amir Onn; Du Hwan Choe; Roy S Herbst; Arlene M Correa; Reginald F Munden; Mylene T Truong; Ara A Vaporciyan; Takeshi Isobe; Michael Z Gilcrease; Edith M Marom
Journal:  Radiology       Date:  2005-10       Impact factor: 11.105

6.  Primary pulmonary cavitating carcinomas.

Authors:  M R Chaudhuri
Journal:  Thorax       Date:  1973-05       Impact factor: 9.139

7.  Lung cancer associated with cystic airspaces.

Authors:  Ali O Farooqi; Matt Cham; Lijuan Zhang; Mary Beth Beasley; John H M Austin; Albert Miller; Javier J Zulueta; Heidi Roberts; Cole Enser; Shang-Jyh Kao; M K Thorsen; James P Smith; Daniel M Libby; Rowena Yip; David F Yankelevitz; Claudia I Henschke
Journal:  AJR Am J Roentgenol       Date:  2012-10       Impact factor: 3.959

8.  Cancer Statistics, 2017.

Authors:  Rebecca L Siegel; Kimberly D Miller; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2017-01-05       Impact factor: 508.702

9.  Should cavitated bronchopulmonary cancers be considered a separate entity?

Authors:  J Mouroux; B Padovani; D Elkaïm; H Richelme
Journal:  Ann Thorac Surg       Date:  1996-02       Impact factor: 4.330

10.  Proposal on incorporating blood vessel invasion into the T classification parts as a practical staging system for stage I non-small cell lung cancer.

Authors:  Yujin Kudo; Hisashi Saji; Yoshihisa Shimada; Jun Matsubayashi; Toshitaka Nagao; Masatoshi Kakihana; Jitsuo Usuda; Naohiro Kajiwara; Tatsuo Ohira; Norihiko Ikeda
Journal:  Lung Cancer       Date:  2013-05-08       Impact factor: 5.705

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.